Skip to content

Investigating the effect of acupuncture versus mesotherapy in the treatment of tennis elbow compared to the control group (oral medication and splinting alone)

Investigating the effect of acupuncture versus mesotherapy in the treatment of tennis elbow compared to the control group (oral medication and splinting alone)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250122064481N1
Enrollment
54
Registered
2025-01-24
Start date
2025-02-19
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tennis elbow. Lateral epicondylitis

Interventions

Intervention 1: The first intervention group: to perform mesotherapy with piroxicam, we insert the needle into the skin at an angle of 10 degrees and horizontally. The needle entry point is the acupun

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 70 Years

Inclusion criteria

Inclusion criteria: Completing and signing the consent form Clinical diagnosis of tennis elbow in the form of pain in the external epicondyle region of the humerus bone by local pressure and wrist extension against resistance Age between 25 and 70 years At least 3 months have passed since the onset of symptoms They have not responded to primary and conservative treatments

Exclusion criteria

Exclusion criteria: Any clinical symptoms of effusion, inflammation, redness and warmth of the involved area Having uncontrolled diabetes, rheumatic diseases and vascular collagen, myopathy, any serious systemic and local infection, Brucella, bleeding diseases History of surgery in the elbow joint of the affected side Severe deformity of the upper limbs Inability to communicate and complete questionnaires History of allergies and allergic reactions to the drugs used, history of significant liver, kidney, brain and cardiopulmonary disorders, history of injections in or around the affected joint in the last 3 months, history of elbow and upper limb physiotherapy in the last 1 month Stable use of NASID in the last 48 hours Pregnant and lactating women, people with cancer People who are using anticoagulants

Design outcomes

Primary

MeasureTime frame
Intensity of pain. Timepoint: Before starting the treatment and 2 and 4 weeks after the treatment. Method of measurement: Visual Analog Scale.;Performance. Timepoint: Before starting the treatment and 2 and 4 weeks after the treatment. Method of measurement: Patient-Rated Tennis Elbow Evaluation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahshid Malekmohamadi

Shiraz University of Medical Sciences

malekmohammadi@sums.ac.ir+98 34 3261 1443

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026